Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,351) with videos related to
Page
of 136
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2025
Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy
S Dugas-Breit, A Forschner, M Erdmann, et al.
European Journal of Dermatology : EJD
|
January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
Johan Hansson, Karen Bartley, Thomas Karagiannis, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
British Journal of Cancer
|
August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial
I Witzel, S Loibl, G von Minckwitz, et al.
Plos One
|
September 15, 2010
Identifying Fishes through DNA Barcodes and Microarrays
Marc Kochzius, Christian Seidel, Aglaia Antoniou, et al.
The Lancet. Oncology
|
April 1, 2019
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial
Dirk Schadendorf, Axel Hauschild, Mario Santinami, et al.
Scientific Reports
|
March 1, 2017
Rapid adaptation to microgravity in mammalian macrophage cells
Cora S Thiel, Diane de Zélicourt, Svantje Tauber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected <i>BRAF</i> V600-Mutant Stage III Melanoma
Axel Hauschild, Reinhard Dummer, Dirk Schadendorf, et al.
Cancers
|
November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones
Sergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
The Oncologist
|
March 5, 2013
Analysis of dermatologic events in vemurafenib-treated patients with melanoma
Mario E Lacouture, Madeleine Duvic, Axel Hauschild, et al.
Page
of 136
Search research articles
Search
Showing results (1101-1110 of 1,351) with videos related to
Sort By:
Page
of 136
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2025
Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy
S Dugas-Breit, A Forschner, M Erdmann, et al.
European Journal of Dermatology : EJD
|
January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
Johan Hansson, Karen Bartley, Thomas Karagiannis, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
British Journal of Cancer
|
August 16, 2012
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial
I Witzel, S Loibl, G von Minckwitz, et al.
Plos One
|
September 15, 2010
Identifying Fishes through DNA Barcodes and Microarrays
Marc Kochzius, Christian Seidel, Aglaia Antoniou, et al.
The Lancet. Oncology
|
April 1, 2019
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial
Dirk Schadendorf, Axel Hauschild, Mario Santinami, et al.
Scientific Reports
|
March 1, 2017
Rapid adaptation to microgravity in mammalian macrophage cells
Cora S Thiel, Diane de Zélicourt, Svantje Tauber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2018
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected <i>BRAF</i> V600-Mutant Stage III Melanoma
Axel Hauschild, Reinhard Dummer, Dirk Schadendorf, et al.
Cancers
|
November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones
Sergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
The Oncologist
|
March 5, 2013
Analysis of dermatologic events in vemurafenib-treated patients with melanoma
Mario E Lacouture, Madeleine Duvic, Axel Hauschild, et al.
Page
of 136